Nuvectis Pharma, Inc. (NVCT)

USD 4.7

(-8.02%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020
Total Assets 19.18 Million 20.4 Million 6.65 Million -
Total Current Assets 19.18 Million 20.4 Million 5.83 Million -
Cash And Short Term Investments 19.12 Million 19.99 Million 5.74 Million -
Cash and Cash Equivalents 19.12 Million 19.99 Million 5.74 Million -
Short Term Investments - - - -
Net Receivables - - - -
Inventory - - - -
Other Current Assets 59 Thousand 412 Thousand 91 Thousand -
Total Non-Current Assets - - 824 Thousand -
Net PPE - - - -
Good Will And Intangible Assets - - - -
Good Will - - - -
Intangible Assets - - - -
Long-Term Investments - - - -
Tax Assets - - - -
Other Non Current Assets - - 824 Thousand -
Other Assets - - - -
Total Liabilities 6.98 Million 6.18 Million 17.66 Million 10 Thousand
Total Current Liabilities 6.98 Million 6.18 Million 2.41 Million 10 Thousand
Account Payables 2.77 Million 2.91 Million 1.05 Million 10 Thousand
Tax Payables - - - -
Short Term Debt - - - -
Deferred Revenue - - - -
Other Current Liabilities 4.21 Million 3.27 Million 1.36 Million -
Total Non Current Liabilities - 2.91 Million 15.24 Million -
Long-Term Debt - - - -
Deferred Revenue Non Current - - - -
Deferred Tax Liabilities Non Current - - - -
Other Non Current Liabilities - - - -
Other Liabilities - -2.91 Million - -
Total Equity 12.2 Million 14.21 Million -11 Million -10 Thousand
Stock Holders Equity 12.2 Million 14.21 Million -11 Million -10 Thousand
Common Stock 17.76 Billion 14.75 Billion - -
Retained Earnings -54.24 Million -31.98 Million -12.9 Million -10 Thousand
Accumulated other comprehensive income - -14.75 Billion - -
Common Stock Equity 12.2 Million 14.21 Million -11 Million -10 Thousand
Capital Lease Obligation - - - -
Total Investments - - - -
Total Debt - - - -
Net Debt -19.12 Million -19.99 Million -5.74 Million -

Balance Sheet Charts